| ¿µ¹® | Parkinson disease | ÇÑ±Û | ÆÄŲ½¼º´ |
|---|---|---|---|
| ¼³¸í | ³ªÀÌµç »ç¶÷¿¡°Ô ¹ß»ýÇÏ´Â ½Å°æ°èÀÇ ÅðÇິÀÌ´Ù. ÁÖ·Î ¿îµ¿À» ´ã´çÇÏ´Â Áß°£³úºÎÀ§°¡ ħ¹üµÈ´Ù. ¿øÀÎÀº ¹ÙÀÌ·¯½º, ¾à¹°, ȤÀº µ¿¸Æ°æÈÁõ µîÀ¸·Î ¾Ë·ÁÁø °æ¿ìµµ ÀÖÀ¸³ª, ¿øÀÎÀ» ¾Ë ¼ö ¾ø´Â °æ¿ì°¡ ¸¹´Ù. Áõ»óÀº °¡¸é¾ó±¼, ¾²·¯Áú °Í °°Àº °ÉÀ½°ÉÀÌ, ¼Õ¶³¸², ±ÙÀ°ÀÇ °Á÷, ¾ÕÀ¸·Î ±â¿ï¾îÁø ÀÚ¼¼ µîÀÓ. Ä¡·á´Â Ưº°ÇÑ °ÍÀÌ ¾øÀ¸¸ç, ´ë°³ º¸Á¸Àû Ä¡·á(¿ÏÄ¡¸¦ ¸ñÀûÀ¸·Î ÇÏÁö ¾Ê°í ´ÜÁö ȯÀÚÀÇ »ýȰÀ» º¸Á¶ÇØÁÖ´Â Á¤µµÀÇ Ä¡·á)¸¦ ½ÃÇàÇÑ´Ù. ÃÖ±Ù, Á×Àº žÆÀÇ ³ú¸¦ À̽ÄÇÏ´Â ³ú À̽ļú¿¡ ÀÇÇÑ Ä¡·áÈ¿°ú°¡ ³ô´Ù´Â º¸°í°¡ ÀÖ´Ù. |
||
| ¿µ¹® | endemic disease | ÇÑ±Û | dzÅ亴 |
|---|---|---|---|
| ¼³¸í | Àΰ£»çȸ¿¡ Ç×»ó Á¸ÀçÇÏÁö¸¸ Ư¼öÇÑ ±âÈijª ÅäÁú·Î ÀÎÇÏ¿© ƯÁ¤Áö¿ª¿¡¸¸ Á¸ÀçÇÏ´Â »ç¸Á·üÀÌ ³·°í, ÀÓ»óÀûÀ¸·Îµµ µå¹°°Ô º¼ ¼ö ÀÖ´Â º´. ƯÈ÷ ±× ÅäÁöÀÇ Ç³Åä-±âÈÄ-»ý¹°-Åä¾ç µîÀÇ ÀÚ¿¬È¯°æ°ú ±× Áö¹æ ÁÖ¹ÎÀÇ Ç³¼Ó-½À°ü-ÀνÀ µîÀÌ º¹ÀâÇÏ°Ô ¾ôÇô¼ »ý±ä Ư¼öÇÑ º´À» °¡¸®Å²´Ù. ÀϹÝÀûÀ¸·Î ±× Áö¹æ ÁÖ¹ÎÀÇ »ç¸Á·üÀº ±×´ÙÁö ³ôÁö ¾ÊÁö¸¸ ±ÙÀýµÇ±â ¾î·Á¿î °ÍÀÌ Æ¯Â¡ÀÌ´Ù. Áö¹æº´À̶ó´Â ¸»Àº ¾î´À Áö¹æ¿¡ ÇÑÁ¤ÇÏ¿© º¼ ¼ö ÀÖ´Â º´À̶ó´Â Á¡¿¡¼´Â °°Áö¸¸, dzÅäȯ°æ°ú ¹ÐÁ¢ÇÑ °ü°è°¡ ÀÖ´Ù´Â µ¥¼ º¸¸é dzÅ亴À̶ó´Â ¿ë¾î°¡ ÀûÀýÇÏ´Ù. ±¹³»ÀûÀ¸·Î´Â ÂêÂê°¡¹«½Ãº´, ¾ß»ýÅä³¢º´, ·¾Å佺ÇǶóÁõ µîÀÌ ¾Ë·ÁÁ® ÀÖ°í, ¼¼°èÀûÀ¸·Î´Â ¸»¶ó¸®¾Æ, Ȳ¿, ÆäÆ®½º, ÀϺ»ÁÖÇ÷ÈíÃæÁõ µîÀÌ ¾Ë·ÁÁ® ÀÖ´Ù. |
||
| ¿µ¹® | Hodgkin's disease | ÇÑ±Û | È£ÁöŲº´ |
|---|---|---|---|
| ¼³¸í | ¾Ç¼º¸²ÇÁÁ¾ÀÇ ÇÑ ÇüÅÂÀÌ´Ù. È£ÁöŲº´Àº ¹æ»ç¼± Ä¡·á¿¡ ´ë´ÜÈ÷ ¿¹¹ÎÇØ¼ ÃæºÐÇÑ ¾çÀÇ ¹æ»ç¼±À¸·Î ¿ÏÀüÇÑ ±ÙÄ¡Àû Ä¡·á°¡ °¡´ÉÇÏ´Ù. |
||
| AID | acquired immunodeficiency disease; acute infectious disease; acute ionization detector; Agency for I... |
|---|---|
| BD | barbital-dependent; barbiturate dependence; base deficit; base of prism down; basophilic degeneratio... |
| CAD | cadaver, cadaveric; cold agglutinin disease; compressed air disease; computer-assisted design; compu... |
| CSD | carotid sinus denervation; cat scratch disease; combined system disease; conditionally streptomycin ... |
| CVD | cardiovascular disease; cerebrovascular disease; collagen vascular disease; color-vision-deviant |
| light chain-related amyloidosis | A form of primary amyloidosis in which the fibrillar amyloid deposits are derived from the amino terminal variable region of the light chains of immunoglobulin; seen in B-lymphocyte and plasma-cells dyscrasias. (05 Mar 2000) |
|---|---|
| long chain | In bacteriology, a continuous line of more than eight cells. (05 Mar 2000) |
| long-chain 3-hydroxyacyl CoA dehydrogenase | <enzyme> Deficiency may cause some cases of hypoglycaemic 3-hydroxydicarboxylic aciduria Registry number: EC 1.1.1.211 Synonym: l-chad (26 Jun 1999) |
| long-chain-acyl-CoA dehydrogenase | <enzyme> Flavoprotein; forms with another flavoprotein plus EC 1.5.5.1 a system reducing ubiquinone and other acceptors Registry number: EC 1.3.99.- Synonym: lc-acyl-CoA dehydrogenase, long-chain-acyl-coenzyme a dehydrogenase, very-long-chain acyl-CoA dehydrogenase, vlcad (26 Jun 1999) |
| long-chain-alcohol dehydrogenase | <enzyme> Catalyses reversibly the oxidation of a long-chain alcohol in the presence of nad to a long-chain acid anion and NADH Registry number: EC 1.1.1.192 Synonym: fatty alcohol-nad+ oxidoreductase (26 Jun 1999) |
| long-chain-alcohol O-fatty-acyltransferase | <enzyme> Catalyses the final step in biosynthesizing storage liquid waxes from long chain fatty acyl CoA and fatty alcohols; forming predominantly c42 wax esters Registry number: EC 2.3.1.75 Synonym: acyl-coenzyme a-alcohol transacylase, aca transacylase, acyl-CoA-alcohol transacylase, wax-ester synthase (26 Jun 1999) |
| long-chain-fatty-acid-(acyl-carrier-protein) ligase | <enzyme> Fatty acid, acyl-carrier-protein-sh and ATP gives acyl-(acyl-carrier-protein), AMP and ppi Registry number: EC 6.2.1.20 Synonym: fatty acid-acyl carrier protein ligase (AMP), acyl-(acyl-carrier-protein)synthetase, aacp synthetase, fatty acyl-acyl carrier protein synthase, vibrio harveyi, acyl-(acyl-carrier-protein) synthetase, acyl-acp synthetase (26 Jun 1999) |
| long-chain-fatty-acid-CoA ligase | <enzyme> Fatty acid thiokinase (long-chain), a ligase forming acyl-CoA, AMP, and pyrophosphate from long-chain fatty acids, ATP, and coenzyme A. Activity is independent of phosphatidylcholine Registry number: EC 6.2.1.3 Synonym: acyl-activating enzyme, dodecanoyl-CoA synthetase, fatty acid thiokinase (long chain), acid-coenzyme a ligase, fatty acid-CoA ligase, acyl-CoA synthetase, acyl-CoA ligase, coash ligase, ciprofibroyl-CoA synthetase, pristanoyl-CoA synthetase, palmityl CoA synthetase, palmitoyl CoA synthetase, palmitoyl CoA ligase, fatty acyl-CoA synthetase, very long chain fatty acid acyl-CoA synthetase, vlcfa acyl-CoA synthetase, nafenopin-CoA ligase, palmitoyl-CoA synthase, faa2 gene product, faa2p protein, vlacs enzyme (26 Jun 1999) |
| long-chain-fatty-acyl-glutamate deacylase | <enzyme> Lca aminoacylase I almost specific to l-glutamate-containing lipoamino acids; lca aminoacylase II acts on fatty acyl amino acids with chain lengths between c11 and c16 Registry number: EC 3.5.1.55 Synonym: lca aminoacylase I, lca aminoacylase II, n-long chain acyl aminoacylase (26 Jun 1999) |
| LTDH short chain dehydrogenase | <enzyme> Has been sequenced; responsible for methotrexate resistance; isolated from leishmania sp. Registry number: EC 1.3.- Synonym: ltdh gene product, pteridine reductase 1, ptr1 gene product, hmtx(r) gene product (26 Jun 1999) |
| aaa disease | Endemic anaemia of ancient Egypt, ascribed in the Papyrus Ebers to intestinal infestation with ancylostoma; now called ancylostomiasis. (05 Mar 2000) |
| ABO haemolytic disease of the newborn | Erythroblastosis foetalis due to maternal-foetal incompatibility with respect to an antigen of the ABO blood group; the foetus possesses A or B antigen which is lacking in the mother, and the mother produces immune antibody which causes haemolysis of foetal erythrocytes. (05 Mar 2000) |
| accumulation disease | A disease characterised by abnormal accumulation of a metabolic product in certain cells and tissues; examples include the mucopolysaccharidoses, lipoidoses. (05 Mar 2000) |
| Acosta's disease | A condition that results from prolonged exposure to high altitude. Symptoms include a continuous dry cough, shortness of breath, poor exercise tolerance, dizziness, headache, sleep difficulty, anorexia, confusion, fatigue and a rapid pulse. Treatment includes the immediate movement to a lower altitude. Prophylaxis has been accomplished successfully with the use of acetazolamide (Diamox). (27 Sep 1997) |
| acquired immunodeficiency disease | Acquired immunodeficiency disease: Disease caused by infection with the human immunodeficiency virus (HIV). (12 Dec 1998) |
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|